143 related articles for article (PubMed ID: 22336590)
1. Prediction of weight loss and regain following dietary, lifestyle, and pharmacologic intervention.
Napolitano A; Miller SR; Murgatroyd PR; Delafont B; Brooke A; Elkhawad M; Tan CY; Virtue S; Vidal-Puig A; Nunez DJ
Clin Pharmacol Ther; 2012 Jun; 91(6):1027-34. PubMed ID: 22336590
[TBL] [Abstract][Full Text] [Related]
2. Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study.
Mathus-Vliegen EM;
Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S31-8; discussion S39. PubMed ID: 16052193
[TBL] [Abstract][Full Text] [Related]
3. Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine.
Apfelbaum M; Vague P; Ziegler O; Hanotin C; Thomas F; Leutenegger E
Am J Med; 1999 Feb; 106(2):179-84. PubMed ID: 10230747
[TBL] [Abstract][Full Text] [Related]
4. Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial.
Wadden TA; Berkowitz RI; Sarwer DB; Prus-Wisniewski R; Steinberg C
Arch Intern Med; 2001 Jan; 161(2):218-27. PubMed ID: 11176735
[TBL] [Abstract][Full Text] [Related]
5. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.
Elfhag K; Finer N; Rössner S
Diabetes Obes Metab; 2008 Jun; 10(6):498-505. PubMed ID: 17593239
[TBL] [Abstract][Full Text] [Related]
6. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the sibutramine effect on satiety with a visual analogue scale in obese adolescents].
Corrêa LL; Platt MW; Carraro L; Moreira RO; Faria Júnior R; Godoy-Matos AF; Meirelles RM; Póvoa LC; Appolinário JC; Coutinho WF
Arq Bras Endocrinol Metabol; 2005 Apr; 49(2):286-90. PubMed ID: 16184258
[TBL] [Abstract][Full Text] [Related]
9. Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. Sibutramine Trial of Obesity Reduction and Maintenance.
Hansen D; Astrup A; Toubro S; Finer N; Kopelman P; Hilsted J; Rössner S; Saris W; Van Gaal L; James W; Goulder M;
Int J Obes Relat Metab Disord; 2001 Apr; 25(4):496-501. PubMed ID: 11319653
[TBL] [Abstract][Full Text] [Related]
10. Sibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients.
Early JL; Apovian CM; Aronne LJ; Fernstrom MH; Frank A; Greenway FL; Heber D; Kushner RF; Cwik KM; Walch JK; Hewkin AC; Blakesley V
Obesity (Silver Spring); 2007 Jun; 15(6):1464-72. PubMed ID: 17557984
[TBL] [Abstract][Full Text] [Related]
11. Changes in regional adiposity and cardio-metabolic function following a weight loss program with sibutramine in obese men with obstructive sleep apnea.
Phillips CL; Yee BJ; Trenell MI; Magnussen JS; Wang D; Banerjee D; Berend N; Grunstein RR
J Clin Sleep Med; 2009 Oct; 5(5):416-21. PubMed ID: 19961024
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of lifestyle modification and pharmacotherapy for obesity.
Wadden TA; Berkowitz RI; Womble LG; Sarwer DB; Phelan S; Cato RK; Hesson LA; Osei SY; Kaplan R; Stunkard AJ
N Engl J Med; 2005 Nov; 353(20):2111-20. PubMed ID: 16291981
[TBL] [Abstract][Full Text] [Related]
13. Effect of sibutramine on weight reduction and insulin resistance in women with polycystic ovary syndrome.
Georgopoulos NA; Katsikis I; Florakis D; Panidis D; Kandarakis ED
Fertil Steril; 2009 Jun; 91(6):e1. PubMed ID: 19362719
[No Abstract] [Full Text] [Related]
14. What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice.
Astrup A; Lundsgaard C
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():29-34. PubMed ID: 9792479
[TBL] [Abstract][Full Text] [Related]
15. Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus.
Fujioka K; Seaton TB; Rowe E; Jelinek CA; Raskin P; Lebovitz HE; Weinstein SP;
Diabetes Obes Metab; 2000 Jun; 2(3):175-87. PubMed ID: 11220553
[TBL] [Abstract][Full Text] [Related]
16. Use of sibutramine to assist obese women with weight loss can be successful in dietitian-led clinics: another tool in the dietitian's toolbox.
Barratt R; Frost G; O'Boyle A; Millward J; Truby H
J Hum Nutr Diet; 2008 Jun; 21(3):248-55. PubMed ID: 18477180
[TBL] [Abstract][Full Text] [Related]
17. Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects.
de Simone G; Romano C; De Caprio C; Contaldo F; Salanitri T; di Luzio Paparatti U; Pasanisi F
Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):24-30. PubMed ID: 15871847
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of pharmaceutical interventions for obesity: weight loss with orlistat and sibutramine in a United Kingdom population-based cohort.
Douglas IJ; Bhaskaran K; Batterham RL; Smeeth L
Br J Clin Pharmacol; 2015 Jun; 79(6):1020-7. PubMed ID: 25641659
[TBL] [Abstract][Full Text] [Related]
19. Sibutramine enhances insulin sensitivity ameliorating metabolic parameters in a double-blind, randomized, placebo-controlled trial.
Tambascia MA; Geloneze B; Repetto EM; Geloneze SR; Picolo M; Magro DO
Diabetes Obes Metab; 2003 Sep; 5(5):338-44. PubMed ID: 12940872
[TBL] [Abstract][Full Text] [Related]
20. Comparison of orlistat and sibutramine in an obesity management program: efficacy, compliance, and weight regain after noncompliance.
Gursoy A; Erdogan MF; Cin MO; Cesur M; Baskal N
Eat Weight Disord; 2006 Dec; 11(4):e127-32. PubMed ID: 17272944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
